मुख्यपृष्ठ › मल्टिपल मायलोमा › नॉर्थ कॅरोलिना › Durham
Durham, NC मधील मल्टिपल मायलोमा साठी क्लिनिकल ट्रायल्स
Durham आणि आजूबाजूच्या ठिकाणी (सुमारे 30 मैलांच्या आत) मल्टिपल मायलोमा साठी 37 अभ्यास सहभागी शोधत आहेत. कोण सहभागी होऊ शकते आणि अभ्यास संघाशी संपर्क कसा साधावा हे पाहण्यासाठी अभ्यास उघडा.
अधिकृत अभ्यास मजकूर (इंग्रजी)
अभ्यासासाठी सहभागी शोधत आहात? हे पृष्ठ शीर्षस्थानी दर्शवा — 30 दिवसांसाठी $99 →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
निवड सुरू आहेफेज 3
- Research Site, Chapel Hill · 10 मैल दूर
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
निवड सुरू आहेफेज 3
- Duke University Medical Center, Durham
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
निवड सुरू आहेफेज 2
- Duke University Medical Center, Durham
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
निवड सुरू आहेफेज 3
- Durham VAMC, Durham
- University of North Carolina, Chapel Hill · 10 मैल दूर
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
निवड सुरू आहेफेज 3
- Durham VAMC, Durham
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
निवड सुरू आहेफेज 2/3
- University of North Carolina at Chapel Hill /ID# 277708, Chapel Hill · 10 मैल दूर
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
निवड सुरू आहेफेज 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 मैल दूर
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
निवड सुरू आहेफेज 3
- Duke University, Durham
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
निवड सुरू आहेफेज 2
- University of North Carolina Medical Center, Chapel Hill · 10 मैल दूर
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
निवड सुरू आहेफेज 1/2
- University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill · 10 मैल दूर
HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
निवड सुरू आहेफेज 2
- Duke University Health System, Durham
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
निवड सुरू आहेफेज 1
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 मैल दूर
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
निवड सुरू आहेफेज 1/2
- GSK Investigational Site, Chapel Hill · 10 मैल दूर
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
निवड सुरू आहेफेज 1
- Duke University Hospital, Durham
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
निवड सुरू आहेफेज 1/2
- Research Site, Durham
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
निवड सुरू आहेफेज 3
- Research Site, Durham
- Research Site, Chapel Hill · 10 मैल दूर
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
निवड सुरू आहे
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 मैल दूर
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
निवड सुरू आहेफेज 1
- Duke Cancer Center, Durham
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
निवड सुरू आहेफेज 2
- UNC Hospitals Adult Oncology Clinics, Chapel Hill · 10 मैल दूर
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
निवड सुरू आहेफेज 1/2
- University of North Carolina at Chapel Hill /ID# 274667, Chapel Hill · 10 मैल दूर
Selinexor and Backbone Treatments of Multiple Myeloma Patients
निवड सुरू आहेफेज 1/2
- Duke Institute of Cancer/ Duke University, Durham
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
निवड सुरू आहेफेज 1
- University of North Carolina /ID# 251203, Chapel Hill · 10 मैल दूर
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
निवड सुरू आहेफेज 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 मैल दूर
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
निवड सुरू आहेफेज 2
- University of North Carolina (Data Collection Only), Chapel Hill · 10 मैल दूर
Registry of Older Patients With Cancer
निवड सुरू आहेनिरीक्षण अभ्यास
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 मैल दूर
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
निवड सुरू आहेफेज 3
- Duke University, Durham
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
निवड सुरू आहेफेज 2
- University of North Carolina, Chapel Hill · 10 मैल दूर
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
निवड सुरू आहेफेज 2
- Duke Comprehensive Cancer Center, Durham
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 मैल दूर
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
निवड सुरू आहेफेज 1
- University of North Carolina Hospitals at Hillsborough, Chapel Hill · 10 मैल दूर
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
निवड सुरू आहेफेज 1/2
- Duke University Health System (DUHS), Durham
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
निवड सुरू आहेफेज 1
- University Of North Carolina Health Care - Hillsborough Campus /ID# 278230, Hillsborough · 13 मैल दूर
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
निवड सुरू आहेफेज 1
- University of North Carolina, Chapel Hill · 10 मैल दूर
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
निवड सुरू आहेफेज 1
- University of North Carolina, Chapel Hill · 10 मैल दूर
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
निवड सुरू आहेफेज 1/2
- Duke University, Durham
- UNC Hospital, Chapel Hill · 10 मैल दूर
Registry for Adults With Plasma Cell Disorders (PCD's)
निवड सुरू आहेनिरीक्षण अभ्यास
- North Carolina Cancer Hospital, Chapel Hill · 10 मैल दूर
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
निवड सुरू आहेनिरीक्षण अभ्यास
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 मैल दूर
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
निवड सुरू आहेफेज 1
- Duke University Health System (DUHS), Durham
इतर शहरांतील मल्टिपल मायलोमा ट्रायल्स
- New York City, NY60 अभ्यास
- Boston, MA42 अभ्यास
- Atlanta, GA41 अभ्यास
- Houston, TX38 अभ्यास
- Nashville, TN32 अभ्यास
- Denver, CO27 अभ्यास
- Rochester, MN24 अभ्यास
- St. Louis, MO24 अभ्यास
- Columbus, OH24 अभ्यास
- Baldwin Park, CA23 अभ्यास
- Chicago, IL22 अभ्यास
- Seattle, WA22 अभ्यास
Durham मधील इतर अभ्यास
- स्तनाचा कर्करोग63 अभ्यास
- कर्करोग (सर्व प्रकार)58 अभ्यास
- नॉन-स्मॉल सेल लंग कॅन्सर39 अभ्यास
- मेटास्टॅटिक कर्करोग33 अभ्यास
- अ‍ॅक्युट मायलोइड ल्युकेमिया33 अभ्यास
- फुफ्फुसाचा कॅन्सर32 अभ्यास
- प्रोस्टेट कर्करोग32 अभ्यास
- कोलोरॅक्टल कॅन्सर28 अभ्यास
- दीर्घकालीन लिम्फोसाइटिक ल्युकेमिया27 अभ्यास
- अंडाशयाचा कर्करोग27 अभ्यास
- हृदयाची अशक्तपणा26 अभ्यास
- स्वादुपिंडाचा कर्करोग24 अभ्यास
ClinicalTrials.gov वरून, 5 ऑक्टो, 2026 रोजी मिळालेली माहिती. प्रत्येक अभ्यासासाठी पात्रतेचे निकष वेगळे असतात; अभ्यास संघ ठरवतो की कोण सहभागी होऊ शकते.